Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.

International journal of cancer - 1 Feb 2006

Uchinokura Shunro, Miyata Shiro, Fukushima Tsuyoshi, Itoh Hiroshi, Nakano Shinichi, Wakisaka Shinichiro, Kataoka Hiroaki

Abstract excerpt

Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional growth factor that is involved in invasive growth of tumor cells via its receptor MET, a protein product of c-met proto-oncogene. HGF activator (HGFA) is a serine proteinase responsible for the activation of proform of HGF/SF (proHGF/SF). In our study, we examined the effects of engineered expression of HGFA on 2 human glioblastoma cell lines...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioblastoma
Share to Mice, Nude

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-met

Share to Receptors, Growth Factor

Share to Serine Endopeptidases

Share to Thrombin

Source

Identifiers

PMID: 16106403
DOI: 10.1002/ijc.21362

Genes

MET
HGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.PMID 16106403Read ↗

HGF/MET Signaling in Malignant Brain TumorsSemantic proximity Read ↗

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaSemantic proximity Read ↗

Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Semantic proximity Read ↗

HGF/c-MET Axis in Tumor Microenvironment and Metastasis FormationSemantic proximity Read ↗

Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.Semantic proximity Read ↗

HGF/SF-Met signaling in tumor progression.Semantic proximity Read ↗

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.Semantic proximity Read ↗

MET: a critical player in tumorigenesis and therapeutic target.Semantic proximity Read ↗

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.Semantic proximity Read ↗

Proliferation and invasion: plasticity in tumor cells.Semantic proximity Read ↗

Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.Semantic proximity Read ↗

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.